US 8143232
Gene fusion targeted therapy
granted A61KA61K31/7105A61P
Quick answer
US patent 8143232 (Gene fusion targeted therapy) held by THE REGENTS OF THE UNIVERSITY OF MICHIGAN expires Mon Mar 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- THE REGENTS OF THE UNIVERSITY OF MICHIGAN
- Grant date
- Tue Mar 27 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61K, A61K31/7105, A61P, A61P35/00